Literature DB >> 17681982

A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder.

Veerle Bogaerts1, Sebastiaan Engelborghs, Samir Kumar-Singh, Dirk Goossens, Barbara Pickut, Julie van der Zee, Kristel Sleegers, Karin Peeters, Jean-Jacques Martin, Jurgen Del-Favero, Thomas Gasser, Dennis W Dickson, Zbigniew K Wszolek, Peter P De Deyn, Jessie Theuns, Christine Van Broeckhoven.   

Abstract

Dementia with Lewy bodies (DLB) represents the second most frequent type of neurodegenerative dementia in the elderly. Although most patients have sporadic DLB, a limited number of DLB families have been described, suggesting that genetic factors may contribute to DLB pathogenesis. Here, we describe a three-generation Belgian family with prominent dementia and parkinsonism, consistent with a diagnosis of DLB, that was autopsy confirmed for the index patient. In a genome-wide scan and subsequent finemapping of candidate loci we obtained significant linkage to 2q35-q36 (Z = 3.01 at D2S1242). Segregation analysis defined a candidate region of 9.2 Mb between D2S433 and chr2q36.3-8, adjacent to the previously reported PARK11 locus. In addition, haplotype sharing studies in another DLB family of close geographical origin with similar clinical and neuropathological features highlighted the specificity of a 2q35-q36 haplotype harbouring a pathogenic mutation that causes DLB in the Belgian family. So far, extensive sequence analysis of five candidate genes within the 2q35-q36 region has not revealed a disease-causing mutation. Together, our data re-emphasize the genetic heterogeneity of DLB, and strongly support the existence of a gene for familial DLB on 2q35-q36. Once identified this will be the first novel causal gene for DLB and can be expected to open new avenues for biological studies of the disease process.

Entities:  

Mesh:

Year:  2007        PMID: 17681982     DOI: 10.1093/brain/awm167

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

Review 1.  Recent advances in the genetics of dementia with lewy bodies.

Authors:  Vincenzo Bonifati
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 2.  Genetics and underlying pathology of dementia.

Authors:  Beata Ferencz; Lotte Gerritsen
Journal:  Neuropsychol Rev       Date:  2015-01-08       Impact factor: 7.444

3.  Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia.

Authors:  Shinsuke Fujioka; Christina Sundal; Audrey J Strongosky; Monica Case Castanedes; Rosa Rademakers; Owen A Ross; Carles Vilariño-Güell; Matthew J Farrer; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2012-11-04       Impact factor: 17.088

4.  UPDATE ON DEMENTIA WITH LEWY BODIES.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

Review 5.  New Therapeutic Strategies for Lewy Body Dementias.

Authors:  Latha Velayudhan; Dominic Ffytche; Clive Ballard; Dag Aarsland
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 6.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

7.  Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma.

Authors:  Candy Kumps; Nadine Van Roy; Lien Heyrman; Dirk Goossens; Jurgen Del-Favero; Rosa Noguera; Jo Vandesompele; Frank Speleman; Katleen De Preter
Journal:  BMC Genomics       Date:  2010-05-12       Impact factor: 3.969

8.  Is GIGYF2 the defective gene at the PARK11 locus?

Authors:  Vincenzo Bonifati
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

Review 9.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

Review 10.  Recent advances in PET imaging for evaluation of Parkinson's disease.

Authors:  Chrissa Sioka; Andreas Fotopoulos; Athanassios P Kyritsis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.